| Today's Open | $8.05 |
|---|---|
| Previous Close | $8.00 |
| Daily Range | $7.94 - $8.06 |
| 52-Week Range | $5.44 - $13.50 |
| Market Cap | $1.7B |
| P/E Ratio | -22.22 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 2,394,611 |
| Average Daily Volume | 5,418,843 |
| Current FY EPS | -$0.12 |
Sector
Healthcare
Industry
Drugs
Arena Pharmaceuticals, Inc. (ARNA) Description
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/
News & Commentary
A list of fascinating statistics about America's biggest health problem.
Weight Loss Isn't Just for Looking Good Anymore
Medical benefits are helping obesity drugs get coverage. Will the government help?Deal Discussions Distract From Disappointing Obesity Drug Sales
Making sense of Vivus' first quarter results for investors.ARNA's Top Competitors
(-0.25%)
(0.63%)
(2.44%)
(-0.50%)